Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Young Adults with PWS, Hypothalamic Obesity, and General Obesity
NCT06901245Phase 4Recruiting
- Start
- May 2025
- Primary completion
- Jun 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in Prader-Willi syndrome (PWS), hypothalamic obesity (HO), obesity. Started May 2025; status: recruiting.
02
Drugs
03
Conditions
Prader-Willi syndrome (PWS)hypothalamic obesity (HO)obesity
Beyond the preview
Go deeper on NCT06901245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901245.